CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV)

CUSIP: 18914F103

Q1 2026 13F Holders as of 31 Mar 2026

Type / Class
Equity / Common Stock
Shares outstanding
416,598,522
Total 13F shares
310,760
Share change
+19,847
Total reported value
$530,789
Price per share
$1.76
Number of holders
5
Value change
+$33,706
Number of buys
2
Number of sells
1

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 18914F103?
CUSIP 18914F103 identifies CLOV - CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of CLOV - CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Vivek Garipalli
3/4/5
Director, 10%+ Owner
mixed-class rows
175,554,161
mixed-class rows
$525,961,700 +$998,997 07 Jan 2026
BlackRock, Inc.
13D/G 13F
Company
7.2%
29,813,646
$83,180,072 $0 30 Jun 2025
VANGUARD GROUP INC
13F
Company
5.6%
23,485,912
$55,191,894 31 Dec 2025
13F
Chamath Palihapitiya
3/4/5
FORMER CHIEF EXECUTIVE OFFICER AND DIRECTOR, 10%+ Owner
class O/S missing
30,147,610
$29,544,657 07 Jul 2021
GREENOAKS CAPITAL PARTNERS LLC
3/4/5
Other*, 10%+ Owner
class O/S missing
25,754,556
$24,466,828 22 Nov 2021
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
2.4%
9,791,208
$23,013,307 31 Dec 2025
13F
STATE STREET CORP
13F
Company
2.2%
9,320,183
$21,902,430 31 Dec 2025
13F
Peter J. Kuipers
3/4/5
Chief Financial Officer
1.4%
5,758,353
$13,301,795 29 Jan 2026
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
1.1%
4,690,904
$11,023,623 31 Dec 2025
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
1.1%
4,491,141
$10,554,181 31 Dec 2025
13F
PNC FINANCIAL SERVICES GROUP, INC.
13F
Company
0.9%
3,763,851
$8,845,050 31 Dec 2025
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.87%
3,634,325
$8,541,992 31 Dec 2025
13F
NORTHERN TRUST CORP
13F
Company
0.76%
3,178,430
$7,469,311 31 Dec 2025
13F
MORGAN STANLEY
13F
Company
0.62%
2,599,028
$6,107,716 31 Dec 2025
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.56%
2,325,253
$5,464,345 31 Dec 2025
13F
Scott J. Leffler
3/4/5
Chief Financial Officer
class O/S missing
4,857,303
$4,760,157 25 Jan 2024
GOLDMAN SACHS GROUP INC
13F
Company
0.43%
1,781,239
$4,185,911 31 Dec 2025
13F
Aric R. Sharp
3/4/5
CEO of Value Based Care
class O/S missing
2,100,665
$3,907,237 09 Aug 2024
UBS Group AG
13F
Company
0.32%
1,315,324
$3,091,011 31 Dec 2025
13F
CLOVER HEALTH INVESTMENTS, CORP. /DE
3/4/5
Chief Technology Officer
class O/S missing
3,093,225
$3,031,361 31 Oct 2023
Bank of New York Mellon Corp
13F
Company
0.28%
1,172,758
$2,755,981 31 Dec 2025
13F
CITADEL ADVISORS LLC
13F
Company
0.28%
1,147,940
$2,697,659 31 Dec 2025
13F
Joseph R. Martin
3/4/5
General Counsel
class O/S missing
2,718,857
$2,664,480 14 Jun 2023
GROUP ONE TRADING LLC
13F
Company
0.26%
1,087,975
$2,556,741 31 Dec 2025
13F
Nuveen, LLC
13F
Company
0.21%
883,536
$2,076,310 31 Dec 2025
13F
Invesco Ltd.
13F
Company
0.21%
863,197
$2,028,513 31 Dec 2025
13F
Chelsea Clinton
3/4/5
Director
class O/S missing
602,814
$1,983,258 06 Jan 2025
Lee Shapiro
3/4/5
Director
class O/S missing
598,622
$1,969,466 06 Jan 2025
Swiss National Bank
13F
Company
0.2%
828,400
$1,946,740 31 Dec 2025
13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
13F
Company
0.19%
779,801
$1,832,533 31 Dec 2025
13F
Soviero Asset Management, LP
13F
Company
0.18%
750,000
$1,762,500 31 Dec 2025
13F
PRINCIPAL FINANCIAL GROUP INC
13F
Company
0.17%
709,482
$1,667,282 31 Dec 2025
13F
IMC-Chicago, LLC
13F
Company
0.15%
642,964
$1,510,965 31 Dec 2025
13F
BARCLAYS PLC
13F
Company
0.15%
637,279
$1,497,605 31 Dec 2025
13F
DEUTSCHE BANK AG\
13F
Company
0.15%
614,952
$1,445,137 31 Dec 2025
13F
Demetrios L. Kouzoukas
3/4/5
Director
0.15%
605,980
$1,424,174 06 Jan 2026
William G. Robinson Jr.
3/4/5
Director
0.14%
597,987
$1,405,389 06 Jan 2026
JANE STREET GROUP, LLC
13F
Company
0.14%
586,497
$1,378,268 31 Dec 2025
13F
Anna U. Loengard
3/4/5
Director
0.14%
584,666
$1,374,081 +$68,755 06 Jan 2026
Nathaniel S. Turner
3/4/5
Director
class O/S missing
1,324,728
$1,258,492 07 Jan 2021
TEACHER RETIREMENT SYSTEM OF TEXAS
13F
Company
0.13%
520,875
$1,224,056 31 Dec 2025
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.12%
518,970
$1,219,580 31 Dec 2025
13F
RHUMBLINE ADVISERS
13F
Company
0.12%
483,390
$1,135,960 31 Dec 2025
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.11%
442,460
$1,039,780 31 Dec 2025
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
0.1%
410,900
$965,615 31 Dec 2025
13F
Legal & General Group Plc
13F
Company
0.1%
406,970
$956,379 31 Dec 2025
13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
13F
Company
0.1%
400,548
$941,288 31 Dec 2025
13F
CHOREO, LLC
13F
Company
0.09%
386,922
$924,744 31 Dec 2025
13F
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.
13F
Company
0.09%
391,059
$918,989 31 Dec 2025
13F
AMERICAN CENTURY COMPANIES INC
13F
Company
0.09%
377,512
$887,153 31 Dec 2025
13F

Institutional Holders of CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV) as of Q1 2026

As of 31 Mar 2026, CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV) was held by 5 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 310,760 shares. The largest 5 holders included Farther Finance Advisors, LLC, Silverleafe Capital Partners, LLC, SIGNATUREFD, LLC, CoreCap Advisors, LLC, and GAMMA Investing LLC. This page lists 5 institutional shareholders reporting positions in this security for the Q1 2026 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q1 2026 vs Q4 2025 Across Filers

Q4 2025 holders
189
Q1 2026 holders
5
Holder diff
-184
Investor Q4 2025 Shares Q1 2026 Shares Share Diff Share Chg % Q4 2025 Value $ Q1 2026 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.